Apexigen, Inc.
APGN · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|
| Market Cap | $13 | $311 | $331 |
| - Cash | $15 | $23 | $25 |
| + Debt | $0 | $1 | $1 |
| Enterprise Value | -$1 | $288 | $307 |
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Gross Profit | $0 | $0 | $0 |
| % Margin | – | – | – |
| EBITDA | -$33 | -$29 | -$24 |
| % Margin | – | – | – |
| Net Income | -$31 | -$29 | -$24 |
| % Margin | – | – | – |
| EPS Diluted | -1.59 | -0.93 | -0.76 |
| % Growth | -71% | -22.4% | – |
| Operating Cash Flow | -$31 | -$24 | -$20 |
| Capital Expenditures | -$0 | -$0 | $0 |
| Free Cash Flow | -$31 | -$24 | -$20 |